Adamas Pharmaceuticals
ADMS
#7649
Rank
โ‚ฌ0.32 B
Marketcap
7,00ย โ‚ฌ
Share price
0.00%
Change (1 day)
14,613.37%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): โ‚ฌ74.45 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is โ‚ฌ75.11 Million. In 2020 the company made a revenue of โ‚ฌ63.42 Million an increase over the revenue in the year 2019 that were of โ‚ฌ46.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ74.45 M17.38%
2020โ‚ฌ63.42 M36.28%
2019โ‚ฌ46.53 M60.48%
2018โ‚ฌ29 M
2016โ‚ฌ0.48 M-70.15%
2015โ‚ฌ1.63 M-96.57%
2014โ‚ฌ47.56 M-21.45%
2013โ‚ฌ60.55 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Zogenix
ZGNX
โ‚ฌ69.58 M-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Supernus Pharmaceuticals
SUPN
โ‚ฌ0.58 B 672.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ50.80 B 67,532.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.07 B 47,925.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ54.71 B 72,737.88%๐Ÿ‡บ๐Ÿ‡ธ USA